Environmental sustainability: the EIPG perspective
Piero Iamartino Although the impact of medicines on the environment has been highlighted since the 70s of the…
EMA’s pilot scheme for academic and non-profit development of ATMPs
by Giuliana Miglierini Advanced therapy medicinal products (ATMPs) are often developed by academic and non-profit organisations, because of…
Webinar: ICH Q12 Product Lifecycle Management – open road or dead end?
Next EIPG webinar is to be held on Tuesday 18th April 2023 at 17.00 CEST (16.00 BST) in…
A concept paper on the revision of Annex 11
This concept paper addresses the need to update Annex 11, Computerised Systems, of the Good Manufacturing Practice (GMP)…
Draft Guideline on the acceptability of names for human medicinal products
The scope of this guideline is to provide information on the overall procedure for submitting and reviewing the…
Consultation open on the ICH Q13 guideline on continuous manufacturing
by Giuliana Miglierini The new ICH Q13 guideline on the continuous manufacturing of drug substances and drug products…